RA Capital Nexus Fund III, L.P.

Insider profile

RA Capital Nexus Fund III, L.P.'s trades of Sionna Therapeutics Inc's stock


Loading...
Purchase Sale Planned purchase Planned sale Net purchase Net sale Buy signal Sell signal Earnings
Abbreviations B: Buy, S: Sell, PP: Planned purchase, PlS: Planned sale, PrS: Proposed sale, O: Option / Other
Notification date Transaction date Company B/S Transaction type Nb. shares
Price
Value
Number of shares Price Value Details
2025-11-21 2025-11-21 PrS Proposed sale
89,928
27.41
US$530,162
89,928 27.41 US$530,162
2025-11-20 2025-11-20 PrS Proposed sale
1,882
400.77
US$4,939,608
1,882 400.77 US$4,939,608
2025-11-19 2025-11-19 PrS Proposed sale
57,751
334.88
US$2,490,268
57,751 334.88 US$2,490,268
2025-11-18 2025-11-18 PrS Proposed sale
1,770
39.04
US$69,100
1,770 39.04 US$69,100
2025-11-17 2025-11-17 PrS Proposed sale
20,969
39.93
US$837,292
20,969 39.93 US$837,292
2025-10-28 2025-10-28 PrS Proposed sale
17,118
39.45
US$675,305
17,118 39.45 US$675,305
2025-10-24 2025-10-24 PrS Proposed sale
66,672
39.21
US$2,614,209
66,672 39.21 US$2,614,209